New Delhi, Aug. 5 -- Penny stock Welcure Drugs & Pharmaceuticals hit the 5% upper circuit on Tuesday, August 5, defying the weakness in the Indian stock market, bolstered by the stellar Q1 results for the financial year 2025-26 (FY26).

The penny stock hit the day's high of Rs.10.11 apiece in intraday deals today, also its 5% upper price band. The stock settled at this level.

For the quarter ended June 2025, Welcure Drugs & Pharmaceuticals posted a sharp surge in both revenue and profits on a quarter-on-quarter (QoQ) basis, driving the penny stock higher.

Welcure Drugs & Pharmaceuticals' revenue from operations stood at Rs.299.91 crore in Q1FY26, up from Rs.21.21 crore previous quarter (Q4FY25), making it about a 1300% rise on a QoQ bas...